Sign in to view content

Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)

Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Video
Published 2021

Related

Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Early Switch to the Dexamethasone Implant After Sub-Optimal Response to Anti-VEGF Therapy for Diabetic Macular Edema
Shawn Kavoussi, MD
Annual Meeting Talks
2021
Artificial Intelligence Screening for Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Exams
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more